Product ID: UCMIG35I2148
Gabapentin Market Size, Share, Growth Analysis, By Dosage Form(Tablet, Capsule), By Type(Generic, Branded), By Application(Epilepsy, Neuropathic Pain), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy), By Regional(North America, Europe) - Industry Forecast 2024-2031
Report ID:
UCMIG35I2148 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
Gabapentin Market Competitive Landscape
To understand the competitive landscape, we are analyzing key Gabapentin Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Gabapentin Market.
To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.
Key Players Covered in the Report:
- Zydus Pharmaceuticals, Inc.
- Glenmark Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd.
- Ascend Laboratories, LLC
- Apotex Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma.
- Amneal Pharmaceuticals LLC.
- Cipla USA, Inc.
- BP Pharmaceuticals Laboratories Company
- Assertio Holdings, Inc.
- Arbor Pharmaceuticals, Inc.
- Pfizer Inc.
Gabapentin Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
